Media Report Archives - Asieris Pharmaceuticals

Home
About
- Company
- Careers
Technology
Pipeline
Collaboration
News
Contact

Menu

Home
About
- Company
- Careers
Technology
Pipeline
Collaboration
News
Contact

Search

Close

中文

Menu

中文

Media Report

Home > Media Report

Media Report

Asieris initiated TV interview for APL-1202 China phase 2 clinical trial

June 1, 2014

We develop new pharmaceutical drugs for the treatment of genitourinary tumors and related diseases

Links

Company
Technology
Pipeline
Collaboration
News
Careers
Contact

News

Asieris and Photocure Expand Strategic Partnership to Bladder Cancer Diagnosis and Surgery in Mainland China and Taiwan
Asieris Appointed Dr. Yong Xue as Chief Medical Officer and Mr. Xinming Jiang as VP of Sales and Marketing
Company Name Change Announcement
Asieris Awarded the Top 100 China Innovative Pharmaceutical Enterprises
Asieris Announces First Patient Enrollment in the Global Phase III Clinical Trial for APL-1702
Asieris Announces the Completion of their Series D Round of Financing
Asieris Announces Approval of its Phase III Trial of a Novel Single Oral Agent as First-line Treatment for Non-Muscle Invasive Bladder Cancer (NMIBC)

Contact

info@asieris.com
USA
201 King of Prussia Rd
Suite 650
Radnor, PA 19087
China
8F Building 56
1000 Jinhai Rd
Pudong, Shanghai

Join Us

Partner with us

Copyright © 2014-2021 Asieris Pharmaceuticals. All Rights Reserved.

TOP